Print Page   |   Contact Us   |   Sign In   |   Become Member
RRS Podcasts
Blog Home All Blogs
Search all posts for:   

 

View all (82) posts »
 

The Potentials of Tumor Oximetry and Cell Cycle Checkpoint Inhibition

Posted By Administration, Monday, December 14, 2009
Updated: Monday, April 22, 2013

Welcome to the November issue of the Radiation Research podcast!

In this issue, Vered’s News Minutefocuses on the risks of radiation exposure from multiple X-ray imaging tests.

The interview of the month is with Drs. Khan and Eastman from The Dartmouth Medical School and the Dartmouth-Hitchcock Medical Center in New Hampshire, describing the potentials of tumor pO2 measurements and the use of cell cycle checkpoint inhibitors in cancer treatment. This discussion is based on their article that appeared in the November issue of Radiation Research: Radiotherapy in Conjunction with 7-Hydroxystaurosporine: A Multimodal Approach with Tumor pO2 as a Potential Marker of Therapeutic Response

Tags:  tumor radiosensitization 

Share |
Permalink | Comments (0)
 
Membership Management Software Powered by YourMembership  ::  Legal